InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (0 oper.)
Historial del iniciado
ConsejeroCompras declaradas
0
Ventas declaradas
0
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
No hay puntuaciones de señal disponibles.
Browse the detailed record of transactions filed by Beraud Jill, Consejero. Director active across 2 companies, notably Revance Therapeutics, Inc.. Cumulatively, 33 filings have been published. Activity tracked since 5 May 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Beraud Jill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones33 en total
54 títulos0Class A Common StockSEC:0001999371-26-017422:0
8381 títulos0Class A Common StockSEC:0001999371-26-009019:0
75 títulos0Class A Common StockSEC:0001999371-26-004640:0
85 títulos0Class A Common StockSEC:0001999371-25-017124:0
82 títulos0Class A Common StockSEC:0001999371-25-011151:0
88 títulos0Class A Common StockSEC:0001999371-25-005903:0
108.679 títulos0Class A Common StockSEC:0001999371-25-004779:0
56 títulos0Class A Common StockSEC:0001839882-25-013573:0
28.606 títulos@ 3,65 US$100.0% de su flujoCommon StockSEC:0000950170-25-015341:0
60 títulos0Class A Common StockSEC:0001839882-24-039788:0
52 títulos0Class A Common StockSEC:0001999371-24-010538:0
42 títulos0Class A Common StockSEC:0001999371-24-006713:0
15.000 títulos0Common StockSEC:0001479290-24-000084:0
7642 títulos0Class A Common StockSEC:0001999371-24-005255:0
69 títulos0Class A Common StockSEC:0001999371-24-002763:0
87 títulos0Class A Common StockSEC:0001999371-23-000150:0
88 títulos0Class A Common StockSEC:0001209191-23-046788:0
129 títulos0Class A Common StockSEC:0001209191-23-031617:0
3534 títulos0Common StockSEC:0001479290-23-000058:0
77.410 títulos0Common StockSEC:0001209191-23-025241:0
10.251 títulos0Class A Common StockSEC:0001209191-23-025261:0
87 títulos0Class A Common StockSEC:0001209191-23-013528:0
190 títulos0Class A Common StockSEC:0001209191-22-058617:0
152 títulos0Class A Common StockSEC:0001209191-22-046620:0
222 títulos0Class A Common StockSEC:0001209191-22-031970:0
25 de 33 declaraciones
About Beraud Jill
Beraud Jill is Administrateur at Levi Strauss & Co and Revance Therapeutics, Inc. She has 32 filings in total, and across the 32 sampled filings, the period runs from 2021-05-07 to 2026-04-24. The modal transaction nature is Attribution, and the buy and sell amounts are both EUR 0 in the sampled filings.
